Experience with mexidol in neurological practice

I. Yu. Torshin, L. V. Stakhovskaya, E. G. Pepelyaev, V. A. Semenov, Anton G. Nazarenko

S S Korsakov Journal of Neurology and Psychiatry · 2018 · 18 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

Antihypoxic, antioxidant and nootropic effects of mexidol contribute to the improvement of patients with cerebrovascular pathology. The results of clinical studies show that the sequential scheme of using mexidol (first i.v. or i.m., then per os) is effective in the complex therapy of ischemic diseases of the brain, vascular surgery, therapy and rehabilitation of patients with degenerative-dystrophic changes of the spine, treatment of neurodegenerative pathology (including multiple sclerosis, Parkinson's disease and diabetic polyneuropathy), infectious neuropathies (ARVI, herpes, tick-borne encephalitis), neuropsychological and autonomic disorders.

References

9